NEXT GENERATION RNAI

Serial Number 98789219
688

Registration Progress

Application Filed
Oct 7, 2024
Under Examination
Jul 15, 2025
Approved for Publication
May 20, 2025
Published for Opposition
May 20, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jan 15, 2026 180 days

Trademark Image

NEXT GENERATION RNAI

Basic Information

Serial Number
98789219
Filing Date
October 7, 2024
Published for Opposition
May 20, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Jul 15, 2025
Application
Pending
Classes
005 042

Rights Holder

City Therapeutics, Inc.

03
Address
399 Binney Street
Cambridge, MA 02141

Ownership History

City Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

City Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Patrick J. Concannon

USPTO Deadlines

Next Deadline
180 days remaining
NOA E-Mailed - SOU Required
Due Date
January 15, 2026
Extension Available
Until July 15, 2026

Application History

12 events
Date Code Type Description Documents
Jul 15, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 20, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 20, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 14, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 22, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 22, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 22, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 22, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 22, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 10, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 9, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 7, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, nucleic acid therapeutics for use in the treatment of diseases and disorders, namely, genetic, neurologic, gastrointestinal, metabolic, immunological, cardiovascular, ocular, and oncological and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system and kidneys; Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of diseases and disorders, namely, genetic, neurologic, gastrointestinal, metabolic, immunological, cardiovascular, ocular, and oncological and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system and kidneys
Class 042
Scientific research; Scientific research in the fields of pharmaceuticals and medicine; Providing scientific information in the field of pharmaceuticals and medicine; Product development for others in the field of pharmaceuticals and medicine

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RNAI"